Phase 2b BiRCh Study of Brensocatib in CRSsNP Did Not Meet Primary or Secondary Efficacy Endpoints; Safety Consistent with Previous Studies; Insmed Discontinues CRSsNP Program- Company Acquires Phase 2 Ready Monoclonal Antibody for Potential Respiratory and Immunological & Inflammatory Indications- Insmed Incorporated (Nasdaq:INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies […]
Scholastic Corporation (NASDAQ: SCHL) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on the Company's Class A and Common Stock for the third quarter of fiscal 2026. The dividend is payable on March 16, 2026, to all shareholders of record as of the close of business on
Peregrine Energy Solutions LLC (Peregrine), an integrated clean-energy platform focused on utility-scale battery storage, announced today that it is advancing construction of the Mallard Energy Storage (Mallard) project, 30 miles Northeast of Dallas. The 250 MW / 500 MWh installation is a key step in Peregrine's rapid buildout of next-generation grid infrastructure across ERCOT. https://mma.prnewswire.com/media/2196305/PeregrineEnergySolutions_Logo.jpg
(NYSE:OWL),(NasdaqGM:GAUZ),(NYSE:ARE), NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Blue Owl Capital, Inc. (NYSE:OWL), Gauzy Ltd (NASDAQ:GAUZ), and Alexandria Real Estate Equities, Inc. (NYSE:ARE). Stockholders have until the deadlines below
(NASDAQ:CRAN),(NASDAQ:CRANU),(NASDAQ:CRANR), PHILADELPHIA, PA, Dec. 17, 2025 (GLOBE NEWSWIRE) — Crane Harbor Acquisition Corp. II (NASDAQ:CRANU) (the “Company”) today announced the closing of its upsized initial public offering of 34,500,000 units, which includes 4,500,000 units issued pursuant to the exercise by the underwriters of their over-allotment option in full. The offering was priced at $10.00 per
(Paris:IVA), Daix (France), New York City (New York, United States), December 17, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announced that CEO Andrew Obenshain has been invited to present a
Micron Technology, Inc. Reports Results for the First Quarter of Fiscal 2026 AI demand acceleration and Micron execution drive record fiscal Q1 results, including highest ever free cash flow GlobeNewswire December 17, 2025 BOISE, Idaho, Dec. 17, 2025 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU) today announced results for its first quarter of fiscal
Kalaris Therapeutics Reports Positive Initial Phase 1a Data for TH103 in Treatment-Naive Neovascular AMD GlobeNewswire December 17, 2025 TH103 showed mean 10-letter gain in visual acuity and rapid, robust anatomic improvement at Month 1, following a single injection TH103 was generally well tolerated, supporting further dose escalation beyond 2.5 mg TH103 showed a 27 to
VITEC and Actelis Networks Announce Partnership to Bring IPTV to RF-Only Facilities Partnership will combine VITEC's IPTV platform with Actelis' hybrid networking Gigaline technology to unlock high-performance video delivery without rewiring for legacy infrastructure GlobeNewswire December 17, 2025 Paris, France and Sunnyvale, Calif, Dec. 17, 2025 (GLOBE NEWSWIRE) — VITEC, a global leader in IPTV
The Board of Directors of SEI Investments Company (NASDAQ: SEIC) on Dec. 12, 2025 declared a regular semi-annual dividend of $0.52 per share, an increase from the prior semi-annual dividend of $0.49.The cash dividend will be payable to shareholders of record on Dec. 29, 2025, with a payment date of Jan. 12, 2026. About SEI®